Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.21.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 49 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Operating Activities:          
Net loss     $ (26,001) $ (10,006)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization [note 3]     188 191  
Stock-based compensation [note 6 [c] and note 6 [d]] $ 530 $ 281 1,693 891  
Shares issued as settlement with trade vendor     41    
Changes in operating assets and liabilities:          
Grant receivable [note 2]     (151)    
Prepaid expenses and other assets     (146) (1,120)  
Accounts payable     483 (533)  
Accrued liabilities other     (390) 56  
Accrued clinical liabilities     304 (294)  
Accrued compensation     (233) (176)  
Lease obligation [note 7]     (10) (3)  
Net cash used in operating activities     (24,222) (10,994)  
Financing Activities:          
Proceeds from exercise of warrants     339 3,080  
Net cash provided by financing activities     21,682 16,740  
Investing Activities:          
Purchase of property and equipment       (17)  
Net cash used in investing activities       (17)  
Effect of exchange rate changes on cash     (1)    
Net increase (decrease) in cash, cash equivalents and restricted cash     (2,541) 5,729  
Cash, cash equivalents and restricted cash at beginning of the period     35,903 16,714  
Cash, cash equivalents and restricted cash at end of the period $ 33,362 $ 22,443 33,362 22,443 $ 33,362
April 2020 Private Placement [Member]          
Financing Activities:          
Proceeds financing and purchase agreement, net of issuance costs       1,579  
December 2019 Public Offering [Member]          
Financing Activities:          
Financing costs relating to public offering and purchase agreement       (34)  
July 2020 Registered Direct Offering [Member]          
Financing Activities:          
Proceeds from offering, net of issuance costs       5,307  
May 2021 Public Offering [Member]          
Financing Activities:          
Proceeds from offering, net of issuance costs     $ 21,343    
August 2020 Public Offering [Member]          
Financing Activities:          
Proceeds from offering, net of issuance costs       6,822  
LPC [Member]          
Financing Activities:          
Financing costs relating to public offering and purchase agreement         $ (500)
LPC [Member] | Purchase Agreement [Member]          
Financing Activities:          
Financing costs relating to public offering and purchase agreement       $ (14)